Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cereb Cortex ; 30(6): 3528-3542, 2020 05 18.
Article in English | MEDLINE | ID: mdl-32026946

ABSTRACT

Acetylcholine (ACh) is known to regulate cortical activity during different behavioral states, for example, wakefulness and attention. Here we show a differential expression of muscarinic ACh receptors (mAChRs) and nicotinic ACh receptors (nAChRs) in different layer 6A (L6A) pyramidal cell (PC) types of somatosensory cortex. At low concentrations, ACh induced a persistent hyperpolarization in corticocortical (CC) but a depolarization in corticothalamic (CT) L6A PCs via M 4 and M1 mAChRs, respectively. At ~ 1 mM, ACh depolarized exclusively CT PCs via α4ß2 subunit-containing nAChRs without affecting CC PCs. Miniature EPSC frequency in CC PCs was decreased by ACh but increased in CT PCs. In synaptic connections with a presynaptic CC PC, glutamate release was suppressed via M4 mAChR activation but enhanced by nAChRs via α4ß2 nAChRs when the presynaptic neuron was a CT PC. Thus, in L6A, the interaction of mAChRs and nAChRs results in an altered excitability and synaptic release, effectively strengthening CT output while weakening CC synaptic signaling.


Subject(s)
Acetylcholine/metabolism , Neocortex/metabolism , Pyramidal Cells/metabolism , Receptors, Muscarinic/metabolism , Receptors, Nicotinic/metabolism , Synaptic Transmission/physiology , Acetylcholine/pharmacology , Animals , Cholinergic Agonists/pharmacology , Excitatory Postsynaptic Potentials , Glutamic Acid/metabolism , Neocortex/drug effects , Neural Pathways , Patch-Clamp Techniques , Pyramidal Cells/drug effects , Rats , Receptor, Muscarinic M1/drug effects , Receptor, Muscarinic M1/metabolism , Receptor, Muscarinic M4/drug effects , Receptor, Muscarinic M4/metabolism , Receptors, Muscarinic/drug effects , Receptors, Nicotinic/drug effects , Synaptic Transmission/drug effects , Thalamus
2.
Nat Protoc ; 7(2): 394-407, 2012 Feb 02.
Article in English | MEDLINE | ID: mdl-22301777

ABSTRACT

In this report, we describe a reliable protocol for biocytin labeling of neuronal tissue and diaminobenzidine (DAB)-based processing of brain slices. We describe how to embed tissues in different media and how to subsequently histochemically label the tissues for light or electron microscopic examination. We provide a detailed dehydration and embedding protocol using Eukitt that avoids the common problem of tissue distortion and therefore prevents fading of cytoarchitectural features (in particular, lamination) of brain tissue; as a result, additional labeling methods (such as cytochrome oxidase staining) become unnecessary. In addition, we provide correction factors for tissue shrinkage in all spatial dimensions so that a realistic neuronal morphology can be obtained from slice preparations. Such corrections were hitherto difficult to calculate because embedding in viscous media resulted in highly nonlinear tissue deformation. Fixation, immunocytochemistry and embedding procedures for light microscopy (LM) can be completed within 42-48 h. Subsequent reconstructions and morphological analyses take an additional 24 h or more.


Subject(s)
Brain/cytology , Imaging, Three-Dimensional/methods , Lysine/analogs & derivatives , Animals , Brain/ultrastructure , Mice , Microtomy/methods , Neurons/ultrastructure , Osmium Tetroxide , Rats , Staining and Labeling/methods
3.
EMBO J ; 27(17): 2281-92, 2008 Sep 03.
Article in English | MEDLINE | ID: mdl-19172737

ABSTRACT

Mammalian cell viability is dependent on the supply of the essential fatty acids (EFAs) linoleic and alpha-linolenic acid. EFAs are converted into omega3- and omega6-polyunsaturated fatty acids (PUFAs), which are essential constituents of membrane phospholipids and precursors of eicosanoids, anandamide and docosanoids. Whether EFAs, PUFAs and eicosanoids are essential for cell viability has remained elusive. Here, we show that deletion of delta6-fatty acid desaturase (FADS2) gene expression in the mouse abolishes the initial step in the enzymatic cascade of PUFA synthesis. The lack of PUFAs and eicosanoids does not impair the normal viability and lifespan of male and female fads2 -/- mice, but causes sterility. We further provide the molecular evidence for a pivotal role of PUFA-substituted membrane phospholipids in Sertoli cell polarity and blood-testis barrier, and the gap junction network between granulosa cells of ovarian follicles. The fads2 -/- mouse is an auxotrophic mutant. It is anticipated that FADS2 will become a major focus in membrane, haemostasis, inflammation and atherosclerosis research.


Subject(s)
Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-6/metabolism , Linoleoyl-CoA Desaturase/deficiency , Animals , Blood-Testis Barrier/physiology , Carbohydrate Metabolism , Cell Polarity/physiology , Cell Survival/physiology , Eicosanoids/biosynthesis , Female , Infertility/enzymology , Infertility/genetics , Infertility/pathology , Linoleoyl-CoA Desaturase/genetics , Linoleoyl-CoA Desaturase/metabolism , Lipid Metabolism , Macrophages/enzymology , Macrophages/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Ovarian Follicle/physiology , Sertoli Cells/metabolism , Sertoli Cells/pathology , Thromboembolism/enzymology , Thromboembolism/genetics , Thromboembolism/prevention & control
4.
Am J Pathol ; 171(1): 153-61, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17591962

ABSTRACT

Neutral sphingomyelinase SMPD3 (nSMase2), a sphingomyelin phosphodiesterase, resides in the Golgi apparatus and is ubiquitously expressed. Gene ablation of smpd3 causes a generalized prolongation of the cell cycle that leads to late embryonic and juvenile hypoplasia because of the SMPD3 deficiency in hypothalamic neurosecretory neurons. We show here that this novel form of combined pituitary hormone deficiency is characterized by the perturbation of the hypothalamus-pituitary growth axis, associated with retarded chondrocyte development and enchondral ossification in the epiphyseal growth plate. To study the contribution by combined pituitary hormone deficiency and by the local SMPD3 deficiency in the epiphyseal growth plate to the skeletal phenotype, we introduced the full-length smpd3 cDNA transgene under the control of the chondrocyte-specific promoter Col2a1. A complete rescue of the smpd3(-/-) mouse from severe short-limbed skeletal dysplasia was achieved. The smpd3(-/-) mouse shares its dwarf and chondrodysplasia phenotype with the most common form of human achondrodysplasia, linked to the fibroblast-growth-factor receptor 3 locus, not linked to deficits in the hypothalamic-pituitary epiphyseal growth plate axis. The rescue of smpd3 in vivo has implications for future research into dwarfism and, particularly, growth and development of the skeletal system and for current screening and future treatment of combined dwarfism and chondrodysplasia.


Subject(s)
Bone Development/genetics , Collagen Type II/physiology , Dwarfism/genetics , Growth/genetics , Osteochondrodysplasias/genetics , Sphingomyelin Phosphodiesterase/physiology , Animals , Exostoses, Multiple Hereditary/genetics , Hypothalamo-Hypophyseal System/physiology , Mice , Mice, Knockout , Sphingomyelin Phosphodiesterase/genetics , Transgenes
5.
Biol Chem ; 388(4): 405-18, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17391062

ABSTRACT

Targeted deletion of the stearoyl-CoA desaturase 1 gene (scd1) in mouse causes obesity resistance and a severe skin phenotype. Here, we demonstrate that SCD1 deficiency disrupts the epidermal lipid barrier and leads to uncontrolled transepidermal water loss, breakdown of adaptive thermoregulation and cold resistance, as well as a metabolic wasting syndrome. The loss of omega-hydroxylated very long-chain fatty acids (VLCFA) and ceramides substituted with omega-hydroxylated VLCFA covalently linked to corneocyte surface proteins leads to the disruption of the epidermal lipid barrier in scd1-/- mutants. Artificial occlusion of the skin by topical lipid application largely reconstituted the epidermal barrier and also reversed dysregulation of thermogenesis and cold resistance, as well as the metabolic disturbances. Interestingly, SCD1 deficiency abolished expression of the key transcription factor Lef1, which is essential for interfollicular epidermis, sebaceous glands, and hair follicle development. Finally, the occurrence of SCD1 and a newly described hSCD5 (ACOD4) gene in humans suggests that the scd1-/- mouse mutant might be a valuable animal model for the study of human skin diseases associated with epidermal barrier defects.


Subject(s)
Body Temperature Regulation/physiology , Epidermis/physiology , Lipids/physiology , Obesity/prevention & control , Stearoyl-CoA Desaturase/deficiency , Administration, Topical , Animals , Ceramides/metabolism , Cholesterol/blood , Cold Temperature/adverse effects , Down-Regulation , Energy Metabolism , Epidermis/chemistry , Liver/metabolism , Lymphoid Enhancer-Binding Factor 1/biosynthesis , Mice , Mice, Knockout , Petrolatum/administration & dosage , Petrolatum/therapeutic use , Signal Transduction , Skin Absorption/physiology , Skin Diseases, Genetic/physiopathology , Transcription Factors/biosynthesis , Triglycerides/blood , Wasting Syndrome/etiology , Water Loss, Insensible
SELECTION OF CITATIONS
SEARCH DETAIL
...